Ironwood Pharmaceuticals (IRWD) Change in Acquisitions & Divestments (2010 - 2018)

Ironwood Pharmaceuticals has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting $19.9 million for Q4 2018.

• Change in Acquisitions & Divestments for Q4 2018 came in at $19.9 million, down 28.48% year-over-year; the trailing twelve-month figure through Dec 2018 was $99.2 million (down 71.41% YoY), and the FY2018 annual result was $99.2 million, down 71.41% from the prior year.
• Change in Acquisitions & Divestments came in at $19.9 million for Q4 2018 at Ironwood Pharmaceuticals, up from $16.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $212.0 million in Q3 2015 to a low of $13.9 million in Q2 2018.
• The 5-year median for Change in Acquisitions & Divestments is $48.6 million (2018), against an average of $65.0 million.
• Across the five-year window, Change in Acquisitions & Divestments surged 699.65% in 2015 and tumbled 89.8% in 2016, its largest moves.
• Ironwood Pharmaceuticals' Change in Acquisitions & Divestments stood at $52.5 million in 2014, then jumped by 303.99% to $212.0 million in 2015, then plunged by 84.23% to $33.4 million in 2016, then fell by 16.99% to $27.8 million in 2017, then declined by 28.48% to $19.9 million in 2018.
• The last three Change in Acquisitions & Divestments figures came in at $19.9 million (Q4 2018), $16.8 million (Q3 2018), and $13.9 million (Q2 2018), per Business Quant data.